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Although immunoglobulin measurements are a surrogate
marker of immunity, there is no reliable predictor of
whether a HIV-positive patient will mount adequate sero-14th International Congress on Infectious Diseases (ICID) Abs
lower thoracic spinal cord with hyperintense signal in T2
left hemicord. The major capsid protein (VP1) of the Sabin
virus T1 isolated in feces showed a 96.5% genetic similarity
to Sabin 1 vaccine strain (a 3.5% genetic divergence in this
region).
Conclusion: The occurrence of iVDPVs appears to be very
rare; the majority of patients stopped excretion of the virus
after a certain period or have died. The overriding factor for
the emergence of all VDPVs is the same as for WPV circula-
tion, i.e., low routine OPV coverage rates in children. Thus,
a community can become susceptible to the emergence of
all types of VDPV producing an impact in the public health
of the population. New polio vaccination strategies should
be considered to avoid future VDPV cases and to be aligned
WHO endgame strategies.
doi:10.1016/j.ijid.2010.02.619
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Inﬂuenza vaccine: Immunization rates, knowledge, atti-
tudes and practice of health care workers in Iran in
2008/09
Z. Khazaeipour1,∗, N. ranjbar novin2, N. Hoseini 1
1 Health deputy of Tehran University of Medical Science,
Tehran, Iran, Islamic Republic of
2 Research Development Centerof Imam Khomeini Hospital
Complex, tehran, Iran, Islamic Republic of
Background: Inﬂuenza is an important cause of excessive
morbidity and mortality each winter. Its short incubation
period and efﬁcient transmission from person to per-
son makes inﬂuenza hazardous to the patients and staff
in healthcare facilities. The aims of this study were to
determine inﬂuenza vaccine coverage and evaluate the
knowledge, attitudes and practice about inﬂuenza and vac-
cine.
Methods: This study was a cross-sectional survey that was
performed between October 2008 and February 2009 in 139
health care workers (HCWs) of health deputy of Tehran Uni-
versity of medical science, Tehran, Iran. They received a
self-administered questionnaire and then the research assis-
tant waited to collect them.
Results: The response rate to the questionnaire
was 96.5%. The inﬂuenza vaccination coverage for the
2008—2009 seasons was 66.9% (range, 45% to 62%). Most
HCWs (80.6%) had received an inﬂuenza vaccination in the
past, and 65.4% intended to receive vaccination in the
future year. The main reason given for being immunized
was effectiveness of inﬂuenza vaccine (51.4%). The main
reason given for not being immunized was concerned about
sideeffects (23.1%). The knowledge score for the 35 items
ranged from 0 to 34 (mean 17.37). Mean knowledge scores
differed between courses. There was no signiﬁcant differ-
ence in mean knowledge scores between female and male
(P > 0.05) None of independent variables included age, sex,
marital status, having children aged)16 years and courses
were signiﬁcant predictors of taking inﬂuenza immuniza-
tion.
Conclusion: In our study, despite high coverage rate of
inﬂuenza vaccination in comparison with other studies, we
would expect higher rate because of free vaccine availabil-
l
ats e451
ty. The study results indicate that there is the need for
n-going education of Inﬂuenza disease, vaccine action and
enters for Disease Control and Prevention (CDC) recom-
endation among HCWs to increasing vaccination rates.
oi:10.1016/j.ijid.2010.02.620
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Background: International guidelines recommend 23-
olyvalent polysaccharide pneumococcal vaccination (PPV)
or HIV-positive patients with CD4 >200 cells/mm3. His-
orical data shows suboptimal response to vaccination in
IV-positive patients when measured by pneumococcal-
peciﬁc IgG and vaccine serotype-speciﬁc IgG2. There is
ittle data to support the efﬁcacy of vaccination in consis-
ently producing serological response, or assessing the role
f conjugate vaccine in adults.
Methods: In a cross-sectional study, 82 random sam-
les were taken from HIV-positive outpatients. The samples
ere assessed for pneumococcal IgG and IgG2. IgG2 lev-
ls >69g/L are considered good serological evidence of
esponse in the absence of baseline titres with which to com-
are post-vaccination response. Demographic, vaccination
nd laboratory data was recorded. Results were analysed
sing Fisher’s exact test and two-tailed p values with Graph-
ad InStat.
Results: Four patients were excluded with no prior his-
ory of pneumococcal vaccination, and two for incomplete
ata. The remaining 76 patients(M = 47, F = 29) were aged
etween 21 and 71 years (mean = 39.1yrs, SD 9.86) at the
ime of ﬁrst vaccination. Twenty-six patients (34%) received
ooster. Sixty-one patients (80%) were taking ART at the time
f sampling. Thirteen patients (17.1%) had vaccine serotype-
peciﬁc IgG2 titre ‘‘69g/L at the time of sampling.
chieving an IgG2 titre’’ 69g/L was not associated with
ny of the measured variables —– age < vs ‘‘35 yrs at vaccina-
ion(p = 0.54); male vs female sex(p = 0.54); CD4 count <200
s’’ 200 cells/mm3 at ﬁrst vaccination(p = 0.58); CD4 count
350 vs >350 cells/mm3 at ﬁrst vaccination(p = 1.00); CD4
ount <350 vs >350 cells/mm3 at time of sampling(p = 0.34);
RT at sampling time vs no ART(p = 1.00); single vs boosted
oses(p = 0.19); <234 weeks (4, years) since vaccination vs
‘234 weeks(p = 0.37).
Conclusion: In the HAART era only a minority of patients
how adequate levels of vaccine serotype-speciﬁc IgG2
egardless of time since vaccination or booster dosing.ogical response to PPV. Further studies are needed to
ssess the nature of response to PPV, alternative conju-
